LivaNova PLC (NASDAQ:LIVN) major shareholder Two S.C.A. Equinox sold 25,408 shares of the business’s stock in a transaction dated Tuesday, September 13th. The shares were sold at an average price of $60.02, for a total value of $1,524,988.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Two S.C.A. Equinox also recently made the following trade(s):

  • On Friday, September 16th, Two S.C.A. Equinox sold 75,213 shares of LivaNova PLC stock. The shares were sold at an average price of $59.86, for a total value of $4,502,250.18.
  • On Thursday, September 8th, Two S.C.A. Equinox sold 208,000 shares of LivaNova PLC stock. The shares were sold at an average price of $60.52, for a total value of $12,588,160.00.

LivaNova PLC (NASDAQ:LIVN) opened at 59.79 on Monday. The firm’s 50-day moving average price is $59.28 and its 200-day moving average price is $53.67. The firm’s market cap is $2.92 billion. LivaNova PLC has a 12 month low of $46.79 and a 12 month high of $77.00.

Hedge funds have recently modified their holdings of the company. 1832 Asset Management L.P. increased its stake in shares of LivaNova PLC by 3.4% in the first quarter. 1832 Asset Management L.P. now owns 54,600 shares of the company’s stock worth $4,922,000 after buying an additional 1,800 shares during the last quarter. Menta Capital LLC increased its stake in shares of LivaNova PLC by 97.7% in the first quarter. Menta Capital LLC now owns 53,087 shares of the company’s stock worth $2,866,000 after buying an additional 26,228 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of LivaNova PLC by 7.6% in the first quarter. JPMorgan Chase & Co. now owns 108,324 shares of the company’s stock worth $5,847,000 after buying an additional 7,607 shares during the last quarter. BlackRock Institutional Trust Company N.A. increased its stake in shares of LivaNova PLC by 0.3% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 1,241,494 shares of the company’s stock worth $67,016,000 after buying an additional 3,272 shares during the last quarter. Finally, BlackRock Group LTD increased its stake in shares of LivaNova PLC by 22.8% in the first quarter. BlackRock Group LTD now owns 29,868 shares of the company’s stock worth $1,613,000 after buying an additional 5,543 shares during the last quarter. Hedge funds and other institutional investors own 63.67% of the company’s stock.

A number of analysts recently issued reports on the company. WBB Securities reaffirmed a “hold” rating and issued a $60.00 target price on shares of LivaNova PLC in a research report on Wednesday, August 31st. Piper Jaffray Cos. reaffirmed an “overweight” rating and issued a $70.00 target price (up previously from $59.00) on shares of LivaNova PLC in a research report on Friday, August 5th. Six analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $67.20.

LivaNova PLC Company Profile

LivaNova PLC is a medical technology company. The Company operates through three segments: Cardiac Surgery, Cardiac Rhythm Management (CRM) and Neuromodulation. The Cardiac Surgery business unit is engaged in the development, production and sale of cardiovascular surgery products, including oxygenators, heart-lung machines, perfusion tubing systems and systems for autotransfusion and autologous blood washing.

5 Day Chart for NASDAQ:LIVN

Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.